Download PDF
Neuropediatrics 2013; 44(01): 003-019
DOI: 10.1055/s-0032-1330856
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Primary Headache in Children and Adolescents: Update on Pharmacotherapy of Migraine and Tension-Type Headache

Michaela Bonfert
1   Department of Paediatric Neurology and Developmental Medicine, Hauner Children's Hospital, Ludwig-Maximilians-University, Munich, Germany
,
Andreas Straube
2   Department of Neurology, Ludwig-Maximilians-University, Munich, Germany
,
Andreas Sebastian Schroeder
1   Department of Paediatric Neurology and Developmental Medicine, Hauner Children's Hospital, Ludwig-Maximilians-University, Munich, Germany
,
Peter Reilich
3   Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, Munich, Germany
,
Friedrich Ebinger
4   Department of Paediatrics, St Vincenz Hospital Paderborn, Paderborn, Germany
5   Department of Paediatrics, Ruprecht-Karls-University Heidelberg, Germany
,
Florian Heinen
1   Department of Paediatric Neurology and Developmental Medicine, Hauner Children's Hospital, Ludwig-Maximilians-University, Munich, Germany
› Author Affiliations
Further Information

Publication History

30 September 2012

09 October 2012

Publication Date:
09 January 2013 (online)

Also available at
   Permissions and Reprints

Abstract

Primary headache disorders are frequently encountered in the pediatric population. The therapeutic approach consists of a multimodal program, including lifestyle modification, psychotherapeutic intervention, pharmacotherapy, and complementary measures. This systematic review focuses on the pharmacotherapy of pediatric migraine and tension-type headache (TTH). In addition to the general treatment principles, the results of 33 clinical reports published on the topic since 2008 are outlined in detail. Furthermore, a tabular summary of previously investigated agents not studied since 2008 is given, as is an overview of promising pharmacologic approaches so far only evaluated in adults. A variety of pharmacologic options is available, but high-quality evidence is limited to single agents. At this time, approval is restricted to four triptans and flupirtine for the symptomatic treatment of pediatric acute migraine and TTH, respectively. No agent has been approved for the prevention of pediatric primary headaches. This review does not grade the drugs hierarchically because the complex profiles of many agents differ only slightly or even overlap. However, a detailed expert opinion is provided. On the basis of the outlined facts, the team of physician, patient, and parents has to decide on the most appropriate regimen for the individual situation in the sense of personalized medicine.

Keywords

migraine - tension-type headache - acute headache treatment - preventive headache treatment - prophylactic headache treatment - pediatrics
 

  • References

  • 1 World Health Organization, Lifting the Burden. Atlas of Headache Disorders and Resources in the World 2011. A Collaborative Project of World Health Organization and Lifting The Burden. Geneva: World Health Organization; 2011
    Google Scholar
  • 2 Berg Kelly K, Ehrvér M, Erneholm T, Gundevall C, Wennerberg I, Wettergren L. Self-reported health status and use of medical care by 3,500 adolescents in western Sweden. I. Acta Paediatr Scand 1991; 80 (8–9) 837-843
    CrossrefPubMedGoogle Scholar
  • 3 Roth-Isigkeit A, Thyen U, Raspe HH, Stöven H, Schmucker P. Reports of pain among German children and adolescents: an epidemiological study. Acta Paediatr 2004; 93 (2) 258-263
    CrossrefPubMedGoogle Scholar
  • 4 Ellert U, Neuhauser H, Roth-Isigkeit A. [Pain in children and adolescents in Germany: the prevalence and usage of medical services. Results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50 (5–6) 711-717
    PubMedGoogle Scholar
  • 5 Hershey AD. Pediatric headache: update on recent research. Headache 2012; 52 (2) 327-332
    CrossrefPubMedGoogle Scholar
  • 6 Larsson B, Fichtel A. Headache prevalence and characteristics among school children as assessed by prospective paper diary recordings. J Headache Pain 2012; 13 (2) 129-136
    CrossrefPubMedGoogle Scholar
  • 7 Milde-Busch A, Blaschek A, Borggräfe I, von Kries R, Straube A, Heinen F. [Is there an association between the reduced school years in grammar schools and headache and other health complaints in adolescent students?]. Klin Padiatr 2010; 222 (4) 255-260
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol 2010; 52 (12) 1088-1097
    CrossrefPubMedGoogle Scholar
  • 9 The International Classification of Headache Disorders. 2nd edition. Cephalalgia 2004; 24 (Suppl. 01) 9-160
    CrossrefPubMedGoogle Scholar
  • 10 Rho YI, Chung HJ, Lee KH , et al. Prevalence and clinical characteristics of primary headaches among school children in South Korea: a nationwide survey. Headache 2012; 52 (4) 592-599
    CrossrefPubMedGoogle Scholar
  • 11 Kröner-Herwig B, Heinrich M, Morris L. Headache in German children and adolescents: a population-based epidemiological study. Cephalalgia 2007; 27 (6) 519-527
    CrossrefPubMedGoogle Scholar
  • 12 Fendrich K, Vennemann M, Pfaffenrath V , et al. Headache prevalence among adolescents—the German DMKG headache study. Cephalalgia 2007; 27 (4) 347-354
    CrossrefPubMedGoogle Scholar
  • 13 Blaschek A, Milde-Busch A, Straube A , et al. Self-reported muscle pain in adolescents with migraine and tension-type headache. Cephalalgia 2012; 32 (3) 241-249
    CrossrefPubMedGoogle Scholar
  • 14 Ebinger F, Kropp P, Pothmann R, Heinen F, Evers S. Therapie idiopathischer Kopfschmerzen im Kindes- und Jugendalter. Revidierte Empfehlungen der Gesellschaft für Neuropädiatrie (GNP) und der Deutschen Migräne- und Kopfschmerzgesellschaft (DMKG). Monatsschr Kinderheilkd 2009; 157: 599-610
    CrossrefPubMedGoogle Scholar
  • 15 Khan K, Kunz R, Kleijnen J, Antes G. Systematic Reviews to Support Evidence-Based Medicine: How to Review and Apply Findings of Healthcare Research. London, UK: Royal Society of Medicine, Hodder Education; 2011
    Google Scholar
  • 16 Winner P. Pediatric headache. Curr Opin Neurol 2008; 21 (3) 316-322
    CrossrefPubMedGoogle Scholar
  • 17 Papetti L, Spalice A, Nicita F , et al. Migraine treatment in developmental age: guidelines update. J Headache Pain 2010; 11 (3) 267-276
    CrossrefPubMedGoogle Scholar
  • 18 Hershey AD. Current approaches to the diagnosis and management of paediatric migraine. Lancet Neurol 2010; 9 (2) 190-204
    CrossrefPubMedGoogle Scholar
  • 19 Termine C, Ozge A, Antonaci F, Natriashvili S, Guidetti V, Wöber-Bingöl C. Overview of diagnosis and management of paediatric headache. Part II: therapeutic management. J Headache Pain 2011; 12 (1) 25-34
    CrossrefPubMedGoogle Scholar
  • 20 O'Brien HL, Kabbouche MA, Hershey AD. Treating pediatric migraine: an expert opinion. Expert Opin Pharmacother 2012; 13 (7) 959-966
    CrossrefPubMedGoogle Scholar
  • 21 Jacobs H, Gladstein J. Pediatric headache: a clinical review. Headache 2012; 52 (2) 333-339
    CrossrefPubMedGoogle Scholar
  • 22 Cuvellier JC, Carvalho S, Mars A, Auvin S. Study on management of pediatric migraine by general practitioners in northern France. J Headache Pain 2009; 10 (3) 167-175
    CrossrefPubMedGoogle Scholar
  • 23 Seshia SS, Abu-Arafeh I, Hershey AD. Tension-type headache in children: the Cinderella of headache disorders!. Can J Neurol Sci 2009; 36 (6) 687-695
    PubMedGoogle Scholar
  • 24 Parisi P, Papetti L, Spalice A, Nicita F, Ursitti F, Villa MP. Tension-type headache in paediatric age. Acta Paediatr 2011; 100 (4) 491-495
    CrossrefPubMedGoogle Scholar
  • 25 Manzano S, Doyon-Trottier E, Bailey B. Myth: Ibuprofen is superior to acetaminophen for the treatment of benign headaches in children and adults. CJEM 2010; 12 (3) 220-222
    PubMedGoogle Scholar
  • 26 Mannix LK. A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future. Expert Opin Pharmacother 2008; 9 (6) 1001-1011
    CrossrefPubMedGoogle Scholar
  • 27 Ho TW, Pearlman E, Lewis D , et al; Rizatriptan Protocol 082 Pediatric Migraine Study Group. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia 2012; 32 (10) 750-765
    CrossrefPubMedGoogle Scholar
  • 28 Vollono C, Vigevano F, Tarantino S, Valeriani M. Triptans other than sumatriptan in child and adolescent migraine: literature review. Expert Rev Neurother 2011; 11 (3) 395-401
    CrossrefPubMedGoogle Scholar
  • 29 Linder SL, Mathew NT, Cady RK, Finlayson G, Ishkanian G, Lewis DW. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache 2008; 48 (9) 1326-1336
    CrossrefPubMedGoogle Scholar
  • 30 Lewis DW. Almotriptan for the acute treatment of adolescent migraine. Expert Opin Pharmacother 2010; 11 (14) 2431-2436
    CrossrefPubMedGoogle Scholar
  • 31 Fraser IP, Han L, Han TH , et al. Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized study. Headache 2012; 52 (4) 625-635
    CrossrefPubMedGoogle Scholar
  • 32 Kakisaka Y, Wakusawa K, Sato I , et al. Successful treatment with sumatriptan in a case with cyclic vomiting syndrome combined with 18q- syndrome. J Child Neurol 2009; 24 (12) 1561-1563
    CrossrefPubMedGoogle Scholar
  • 33 Kakisaka Y, Wakusawa K, Haginoya K , et al. Efficacy of sumatriptan in two pediatric cases with abdominal pain-related functional gastrointestinal disorders: does the mechanism overlap that of migraine?. J Child Neurol 2010; 25 (2) 234-237
    CrossrefPubMedGoogle Scholar
  • 34 Hikita T, Kodama H, Kaneko S , et al. Sumatriptan as a treatment for cyclic vomiting syndrome: a clinical trial. Cephalalgia 2011; 31 (4) 504-507
    CrossrefPubMedGoogle Scholar
  • 35 Cleves C, Tepper SJ. Sumatriptan/naproxen sodium combination for the treatment of migraine. Expert Rev Neurother 2008; 8 (9) 1289-1297
    CrossrefPubMedGoogle Scholar
  • 36 Derosier FJ, Lewis D, Hershey AD , et al. Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine. Pediatrics 2012; 129 (6) e1411-e1420
    CrossrefPubMedGoogle Scholar
  • 37 McDonald SA, Hershey AD, Pearlman E , et al. Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents. Headache 2011; 51 (9) 1374-1387
    CrossrefPubMedGoogle Scholar
  • 38 Evers S, May A, Fritsche G , et al. Akuttherapie und Prophylaxe der Migräne. Leitlinie der Deutschen Migräne- und Kopfschmerzgesellschaft und der Deutschen Gesellschaft für Neurologie. Nervenheilkunde 2008; 27: 933-949
    Google Scholar
  • 39 Scagni P, Pagliero R. Headache in an Italian pediatric emergency department. J Headache Pain 2008; 9 (2) 83-87
    CrossrefPubMedGoogle Scholar
  • 40 Kabbouche MA, Vaughan P, Cherney S, Powers SE, Hershey AD. Intractable headache response in a pediatric acute care unit. Cephalalgia 2009; 29: 16-17
    PubMedGoogle Scholar
  • 41 Conicella E, Raucci U, Vanacore N , et al. The child with headache in a pediatric emergency department. Headache 2008; 48 (7) 1005-1011
    CrossrefPubMedGoogle Scholar
  • 42 Herd DW, Babl FE, Gilhotra Y, Huckson S. PREDICT group. Pain management practices in paediatric emergency departments in Australia and New Zealand: a clinical and organizational audit by National Health and Medical Research Council's National Institute of Clinical Studies and Paediatric Research in Emergency Departments International Collaborative. Emerg Med Australas 2009; 21 (3) 210-221
    CrossrefPubMedGoogle Scholar
  • 43 Richer LP, Laycock K, Millar K , et al; Pediatric Emergency Research Canada Emergency Department Migraine Group. Treatment of children with migraine in emergency departments: national practice variation study. Pediatrics 2010; 126 (1) e150-e155
    CrossrefPubMedGoogle Scholar
  • 44 Walker DM, Teach SJ. Emergency department treatment of primary headaches in children and adolescents. Curr Opin Pediatr 2008; 20 (3) 248-254
    CrossrefPubMedGoogle Scholar
  • 45 Bailey B, McManus BC. Treatment of children with migraine in the emergency department: a qualitative systematic review. Pediatr Emerg Care 2008; 24 (5) 321-330
    CrossrefPubMedGoogle Scholar
  • 46 Sarchielli P, Granella F, Prudenzano MP , et al. Italian guidelines for primary headaches: 2012 revised version. J Headache Pain 2012; 13 (Suppl. 02) S31-S70
    CrossrefPubMedGoogle Scholar
  • 47 Legault G, Eisman H, Shevell MI. Treatment of pediatric status migrainosus: can we prevent the “bounce back”?. J Child Neurol 2011; 26 (8) 949-955
    CrossrefPubMedGoogle Scholar
  • 48 Trottier ED, Bailey B, Dauphin-Pierre S, Gravel J. Clinical outcomes of children treated with intravenous prochlorperazine for migraine in a pediatric emergency department. J Emerg Med 2010; 39 (2) 166-173
    CrossrefPubMedGoogle Scholar
  • 49 Trottier ED, Bailey B, Lucas N, Lortie A. Prochlorperazine in children with migraine: a look at its effectiveness and rate of akathisia. Am J Emerg Med 2012; 30 (3) 456-463
    CrossrefPubMedGoogle Scholar
  • 50 Khatri R, Hershey AD, Wong B. Prochlorperazine—treatment for acute confusional migraine. Headache 2009; 49 (3) 477-480
    CrossrefPubMedGoogle Scholar
  • 51 Kabbouche MA, Powers SW, Segers A , et al. Inpatient treatment of status migraine with dihydroergotamine in children and adolescents. Headache 2009; 49 (1) 106-109
    CrossrefPubMedGoogle Scholar
  • 52 Avraham SB, Har-Gil M, Watemberg N. Acute confusional migraine in an adolescent: response to intravenous valproate. Pediatrics 2010; 125 (4) e956-e959
    CrossrefPubMedGoogle Scholar
  • 53 Kabbouche MA, Gilman DK. Management of migraine in adolescents. Neuropsychiatr Dis Treat 2008; 4 (3) 535-548
    PubMedGoogle Scholar
  • 54 Mack KJ. Management of chronic daily headache in children. Expert Rev Neurother 2010; 10 (9) 1479-1486
    CrossrefPubMedGoogle Scholar
  • 55 Hirfanoglu T, Serdaroglu A, Gulbahar O, Cansu A. Prophylactic drugs and cytokine and leptin levels in children with migraine. Pediatr Neurol 2009; 41 (4) 281-287
    CrossrefPubMedGoogle Scholar
  • 56 Eidlitz-Markus T, Dlugatch Y, Haimi-Cohen Y, Goldberg-Stern H, Zeharia A. Nonpharmacologic treatment of migraine with low-dose propranolol or amitriptyline. Pediatr Neurol 2012; 46 (6) 345-349
    CrossrefPubMedGoogle Scholar
  • 57 Straube A, May A, Kropp P , et al. Therapie primärer chronischer Kopfschmerzen: Chronische Migräne, chronischer Kopfschmerz vom Spannungstyp und andere chronische tägliche Kopfschmerzen. Evidenzbasierte Empfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft in Zusammenarbeit mit der Österreichischen Kopfschmerzgesellschaft und der Schweizerischen Kopfwehgesellschaft. Nervenheilkunde 2007; 26: 186-199
    PubMedGoogle Scholar
  • 58 Li BU, Lefevre F, Chelimsky GG , et al; North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr 2008; 47 (3) 379-393
    CrossrefPubMedGoogle Scholar
  • 59 Boles RG, Lovett-Barr MR, Preston A, Li BU, Adams K. Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study. BMC Neurol 2010; 10: 10
    CrossrefPubMedGoogle Scholar
  • 60 Togha M, Malamiri RA, Rashidi-Ranjbar N, Asa S, Mahvelati F, Ashrafi MR. Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: an open, randomized comparative trial with propranolol. Acta Neurol Belg 2012; 112 (1) 51-55
    CrossrefPubMedGoogle Scholar
  • 61 Bidabadi E, Mashouf M. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients. Paediatr Drugs 2010; 12 (4) 269-275
    PubMedGoogle Scholar
  • 62 Peer Mohamed B, Goadsby PJ, Prabhakar P. Safety and efficacy of flunarizine in childhood migraine: 11 years' experience, with emphasis on its effect in hemiplegic migraine. Dev Med Child Neurol 2012; 54 (3) 274-277
    CrossrefPubMedGoogle Scholar
  • 63 Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012; 78 (17) 1346-1353
    CrossrefPubMedGoogle Scholar
  • 64 Apostol G, Lewis DW, Laforet GA , et al. Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study. Headache 2009; 49 (1) 45-53
    CrossrefPubMedGoogle Scholar
  • 65 Apostol G, Pakalnis A, Laforet GA , et al. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents. Headache 2009; 49 (1) 36-44
    CrossrefPubMedGoogle Scholar
  • 66 Unalp A, Uran N, Oztürk A. Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine. J Child Neurol 2008; 23 (12) 1377-1381
    CrossrefPubMedGoogle Scholar
  • 67 Hikita T, Kodama H, Nakamoto N , et al. Effective prophylactic therapy for cyclic vomiting syndrome in children using valproate. Brain Dev 2009; 31 (6) 411-413
    CrossrefPubMedGoogle Scholar
  • 68 Yurekli VA, Akhan G, Kutluhan S, Uzar E, Koyuncuoglu HR, Gultekin F. The effect of sodium valproate on chronic daily headache and its subgroups. J Headache Pain 2008; 9 (1) 37-41
    CrossrefPubMedGoogle Scholar
  • 69 Cruz MJ, Valencia I, Legido A , et al. Efficacy and tolerability of topiramate in pediatric migraine. Pediatr Neurol 2009; 41 (3) 167-170
    CrossrefPubMedGoogle Scholar
  • 70 Lewis D, Winner P, Saper J , et al. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 2009; 123 (3) 924-934
    CrossrefPubMedGoogle Scholar
  • 71 Miano S, Parisi P, Pelliccia A, Luchetti A, Paolino MC, Villa MP. Melatonin to prevent migraine or tension-type headache in children. Neurol Sci 2008; 29 (4) 285-287
    CrossrefPubMedGoogle Scholar
  • 72 Ahmed K, Oas KH, Mack KJ, Garza I. Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache. Pediatr Neurol 2010; 43 (5) 316-319
    CrossrefPubMedGoogle Scholar
  • 73 Kabbouche M, O'Brien H, Hershey AD. OnabotulinumtoxinA in pediatric chronic daily headache. Curr Neurol Neurosci Rep 2012; 12 (2) 114-117
    CrossrefPubMedGoogle Scholar
  • 74 Chan VW, McCabe EJ, MacGregor DL. Botox treatment for migraine and chronic daily headache in adolescents. J Neurosci Nurs 2009; 41 (5) 235-243
    CrossrefPubMedGoogle Scholar
  • 75 Schroeder AS, Huss K, Blaschek A , et al. Ten-year follow-up in a case series of integrative botulinum toxin intervention in adolescents with chronic daily headache and associated muscle pain. Neuropediatrics 2012; 43 (1) 27-36
    Article in Thieme ConnectPubMedGoogle Scholar
  • 76 Kernick D, Stapley S, Campbell J, Hamilton W. What happens to new-onset headache in children that present to primary care? A case-cohort study using electronic primary care records. Cephalalgia 2009; 29 (12) 1311-1316
    CrossrefPubMedGoogle Scholar
  • 77 Haag G, Diener HC, May A , et al; DMKG; DGN; OKSG; SKG. Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische Kopfschmerzgesellschaft (ÖKSG) and the Schweizerische Kopfwehgesellschaft (SKG). J Headache Pain 2011; 12 (2) 201-217
    CrossrefPubMedGoogle Scholar
  • 78 Shah UH, Kalra V. Pediatric migraine. Int J Pediatr 2009; 7: 424192
    PubMedGoogle Scholar
  • 79 Schrör K. Aspirin and Reye syndrome: a review of the evidence. Paediatr Drugs 2007; 9 (3) 195-204
    PubMedGoogle Scholar
  • 80 Rapoport AM. The therapeutic future in headache. Neurol Sci 2012; 33 (Suppl. 01) S119-S125
    CrossrefPubMedGoogle Scholar